Rationale for bipolar androgen therapy (BAT) for metastatic prostate cancer

John T. Isaacs; W. Nathaniel Brennen; Samuel R. Denmeade

doi:10.1080/15384101.2017.1360645

Rationale for bipolar androgen therapy (BAT) for metastatic prostate cancer

John T. Isaacs, W. Nathaniel Brennen, Samuel R. Denmeade

School of Medicine

Research output: Contribution to journal › Comment/debate › peer-review

3 Scopus citations

Original language	English (US)
Pages (from-to)	1639-1640
Number of pages	2
Journal	Cell Cycle
Volume	16
Issue number	18
DOIs	https://doi.org/10.1080/15384101.2017.1360645
State	Published - Sep 17 2017

ASJC Scopus subject areas

Molecular Biology
Developmental Biology
Cell Biology

Access to Document

10.1080/15384101.2017.1360645

Cite this

@article{68c7b3aeb90a4ae292e30ec4d7b18a59,

title = "Rationale for bipolar androgen therapy (BAT) for metastatic prostate cancer",

author = "Isaacs, {John T.} and Brennen, {W. Nathaniel} and Denmeade, {Samuel R.}",

year = "2017",

month = sep,

day = "17",

doi = "10.1080/15384101.2017.1360645",

language = "English (US)",

volume = "16",

pages = "1639--1640",

journal = "Cell Cycle",

issn = "1538-4101",

publisher = "Landes Bioscience",

number = "18",

}

TY - JOUR

T1 - Rationale for bipolar androgen therapy (BAT) for metastatic prostate cancer

AU - Isaacs, John T.

AU - Brennen, W. Nathaniel

AU - Denmeade, Samuel R.

PY - 2017/9/17

Y1 - 2017/9/17

UR - http://www.scopus.com/inward/record.url?scp=85028527720&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85028527720&partnerID=8YFLogxK

U2 - 10.1080/15384101.2017.1360645

DO - 10.1080/15384101.2017.1360645

M3 - Comment/debate

C2 - 28820291

AN - SCOPUS:85028527720

SN - 1538-4101

VL - 16

SP - 1639

EP - 1640

JO - Cell Cycle

JF - Cell Cycle

IS - 18

ER -

Rationale for bipolar androgen therapy (BAT) for metastatic prostate cancer

ASJC Scopus subject areas

Access to Document

Other files and links

Cite this